SINO LION VENTURES Ltd Acquires Significant Stake in Indaptus Therapeutics, Inc.

On March 19, 2026, Sino Lion Ventures Limited (Reporting Person) entered into a securities purchase agreement to acquire 259,300 shares of Indaptus Therapeutics, Inc.'s Series AAA Convertible Non-Redeemable Preferred Stock. Each preferred share is convertible into 150 shares of the Issuer's common stock. Following the transaction closing on March 23, 2026, the Reporting Person converted all preferred shares, resulting in the issuance of 38,895,000 shares of common stock. Chenhao Xu may also be deemed to beneficially own these shares, disclaiming ownership except to the extent of any pecuniary interest. This transaction makes Sino Lion Ventures Limited a ten percent owner of Indaptus Therapeutics, Inc.